carbapenems has been researched along with Neutropenia in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (12.50) | 18.2507 |
| 2000's | 15 (31.25) | 29.6817 |
| 2010's | 14 (29.17) | 24.3611 |
| 2020's | 13 (27.08) | 2.80 |
| Authors | Studies |
|---|---|
| Enoki, Y; Hayashi, M; Igarashi, Y; Kojima, N; Liu, X; Matsumoto, K; Mizukami, Y; Morita, T; Nakamura, T; Taguchi, K; Takemura, W; Tashiro, S; Yokoyama, Y | 1 |
| Beeker, A; Coenen, JLLM; de Jonge, NA; de Kreuk, A; Herbers, AH; Janssen, JJWM; Kramer, MHH; Lissenberg-Witte, B; Sikkens, JJ; van Agtmael, MA; Vasmel, W; Ypma, P; Zweegman, S | 1 |
| Gutiérrez-Durán, OA; Hoyos-Pulgarín, JA | 1 |
| Assanelli, AA; Bernardi, M; Carletti, S; Carrabba, MG; Castagna, A; Ciceri, F; Clerici, D; Corti, C; Erbella, F; Farina, F; Galli, L; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Lugli, AP; Lupo Stanghellini, MT; Mancini, N; Mastaglio, S; Nitti, R; Oltolini, C; Peccatori, J; Poli, A; Ripa, M; Ruggeri, A; Scarpellini, P; Tassan Din, C; Xue, E | 1 |
| de Jonge, NA; de la Court, JR; Heijmans, J; Huynh, J; Schade, RP; Sieswerda, E; Sigaloff, KCE; van Dijk, K | 1 |
| Abraham, A; Balaji, V; Bhanuprasad, K; Chacko, B; George, B; George, MM; John, GM; Korula, A; Kulkarni, UP; Mathews, V; Premkumar, PS; Sathya Kumar, AM; Shankar, C; Subramani, K; Varghese, GM | 1 |
| Bilen, NM; Cilli, F; Güner Özenen, G; Kurugöl, Z; Ozdemir Karadas, N; Ozek, G; Sahbudak Bal, Z; Yazici, P; Yildirim Arslan, S | 1 |
| Gopakumar, KG; Jithin, TK; Nair, C; Nirmal, G; Parthiban, R | 1 |
| Chen, Z; Feng, S; Han, M; Jiang, E; Mi, Y; Wang, J; Xiao, Z; Zhang, F; Zhang, T; Zhao, Y; Zhen, S; Zhu, X | 1 |
| Breda, GL; Funke, VAM; Lima, ACM; Loth, G; Nabhan, SK; Nogueira, KDS; Santos, ES; Tomaz, APO | 1 |
| Dinc, G; Doganay, M; Eren, E; Kontas, O | 1 |
| Bruns, AHW; de Groot, MCH; Niessen, FA; Raijmakers, RAP; van der Bruggen, T; van Mourik, MSM | 1 |
| Banerjee, K; Diago-Navarro, E; Fries, BC; Inzerillo, S; Motley, MP | 1 |
| Abdala, E; Akova, M; Álvarez, R; Cano, A; Carratalà, J; Cervera, C; Clemente, WT; Freifeld, A; Gómez, L; Gottlieb, T; Gudiol, C; Gurguí, M; Herrera, F; Maestro-de la Calle, G; Manzur, A; Martín-Dávila, P; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Royo-Cebrecos, C; Ruiz-Camps, I; Sukiennik, TC; Tebe, C | 1 |
| Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK | 1 |
| Crandon, JL; Nicolau, DP; Wiskirchen, DE | 1 |
| Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE | 1 |
| Angebault, C; Bourhis, JH; Chachaty, E; de Botton, S; Gachot, B; Micol, JB; Pasquier, F; Pilorge, S; Woerther, PL | 1 |
| Askin, G; Chen, L; Cohen, N; Gedrimaite, Z; Kreiswirth, BN; Ma, KC; Satlin, MJ; Seo, SK; Soave, R; Walsh, TJ | 1 |
| Harris, PN; Lane, SW; Liborio, M; Paterson, DL; Peri, AM; Righi, E; Wailan, AM | 1 |
| Adil, S; Habib, F; Hasan, R; Idrees, F; Irfan, S; Mehraj, V | 1 |
| Cheong, HJ; Kim, WJ; Lee, J; Song, JY; Sung, AK | 1 |
| Hiraoka, A; Karasuno, T; Kiyomizu, K; Minami, R; Tanimura, A; Yagi, T; Yoshida, H | 1 |
| Ishikawa, T; Ishitsuka, K; Katsuya, H; Sasaki, H; Takamatsu, Y; Takata, T; Tamura, K | 1 |
| Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N | 1 |
| Watanabe, K | 1 |
| Akyüz, C; Büyükpamukçu, M; Cengiz, B; Ceyhan, M; Demir, HA; Kara, A; Kutluk, T; Seçmeer, G; Varan, A; Yağcı-Küpeli, B; Yalçın, B | 1 |
| Bhusal, Y; Mihu, CN; Rolston, KV; Tarrand, JJ | 1 |
| Beyene, J; Dupuis, LL; Lehrnbecher, T; Manji, A; Sung, L | 1 |
| Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohta, K; Ohyashiki, K; Suzuki, K; Tamura, K; Urabe, A | 1 |
| Farnum, C; Havlichek, DH; Kalra, A; Kulhanek, G; Kuti, JL; Nicolau, DP; Scharmen, A; Smith, CL; Stein, GE; Tran, M | 1 |
| Akiyama, N; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A | 1 |
| Gondoh, H; Hanada, S; Ikeda, S; Imamura, Y; Izumi, Y; Kawano, F; Masuda, M; Matsuishi, E; Matsuoka, H; Okamura, S; Saburi, Y; Shibuya, T; Tamura, K; Tsukada, J; Uike, N; Utsunomiya, A | 1 |
| Gudiol, F; Marín, M | 1 |
| Hino, M; Nakamae, H; Ohta, K; Sakamoto, E; Shibata, H; Yamane, T | 1 |
| Fraser, A; Leibovici, L; Paul, M; Yahav, D | 1 |
| Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K | 1 |
| Aisenberg, G; Dickey, BF; Kontoyiannis, DP; Raad, II; Rolston, KV; Safdar, A | 1 |
| Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA | 1 |
| Azuma, R; Harada, H; Mori, H; Niikura, H; Omine, M; Sakai, H; Sanada, M; Shimamoto, K | 1 |
| Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeoung, SJ; Kim, CK; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Lee, HS; Lee, K; Song, YG; Yong, D; Yum, JH | 1 |
| Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I | 1 |
| Amsallem, D; Balbo, L; Castagnola, E; Cometta, A; Engelhard, D; Estavoyer, JM; Ferster, A; Giacchino, M; Giacchino, R; Gibson, B; Glauser, MP; Massimo, L; Shapiro, M; Viscoli, C | 1 |
| Cometta, A; Glauser, MP | 1 |
| Ljungberg, B; Nilsson-Ehle, I; Nyhlén, A | 1 |
| Rolston, KV | 1 |
| Bradley, JS; Garau, J; Lode, H; Quinn, JP; Rolston, KV; Wilson, SE | 1 |
| Butler, K; Gress, J; Lecciones, J; Lee, J; Marshall, D; Pizzo, PA; Roilides, E; Rubin, M; Walsh, T; Weinberger, M | 1 |
9 review(s) available for carbapenems and Neutropenia
| Article | Year |
|---|---|
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
Topics: Acinetobacter; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Drug Resistance, Bacterial; Female; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Israel; Italy; Klebsiella; Klebsiella Infections; Male; Middle Aged; Neutropenia; Prevalence; Pseudomonas | 2017 |
[Fever in patients with cancer].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbapenems; Diagnosis, Differential; Drug Therapy, Combination; Fever; Humans; Naproxen; Neoplasms; Neutropenia; Opportunistic Infections; Vancomycin | 2009 |
A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Neutropenia; Penicillins; Prospective Studies; Risk Assessment | 2012 |
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enzyme Inhibitors; Fever; Humans; Neutropenia; Penicillanic Acid; Penicillins; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome | 2006 |
Empirical treatment of fever in neutropenic children: the role of the carbapenems. International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer and the Gimema Infection Program.
Topics: Carbapenems; Child; Fever; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia | 1996 |
Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Meropenem; Neutropenia; Randomized Controlled Trials as Topic; Thienamycins | 1996 |
Expanding the options for risk-based therapy in febrile neutropenia.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Therapy, Combination; Fever; Gram-Positive Bacterial Infections; Humans; Neutropenia; Risk Assessment | 1998 |
Carbapenems in clinical practice: a guide to their use in serious infection.
Topics: Bacterial Infections; Carbapenems; Child; Drug Resistance, Microbial; Fever; Humans; Intensive Care Units; Meningitis, Bacterial; Neutropenia; Peritonitis; Pneumonia | 1999 |
The febrile neutropenic patient: newer options for empirical therapy.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Neutropenia; Quinolones | 1990 |
8 trial(s) available for carbapenems and Neutropenia
| Article | Year |
|---|---|
Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carbapenems; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neutropenia; Research; Treatment Outcome | 2022 |
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult | 2010 |
Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors.
Topics: Adolescent; Carbapenems; Cefoperazone; Child; Child, Preschool; Female; Humans; Infant; Lymphoma; Male; Neutropenia; Sarcoma; Sulbactam | 2011 |
Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Female; Fever; Hematologic Diseases; Humans; Male; Meropenem; Neutropenia; Prospective Studies; Thienamycins; Treatment Outcome; Young Adult | 2013 |
Pharmacokinetics and monte carlo simulations of doripenem in patients with febrile neutropenia.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Gram-Negative Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Neutropenia; Young Adult | 2012 |
Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
Topics: Adult; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Neutropenia | 2002 |
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Treatment Failure; Treatment Outcome | 2006 |
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
31 other study(ies) available for carbapenems and Neutropenia
| Article | Year |
|---|---|
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefmetazole; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Microbial Sensitivity Tests; Neutropenia | 2021 |
[Risk of infection in cancer patients colonized by extended expectrum p-lactamases and carbapenem producing Enterobacteriaceae].
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hypoalbuminemia; Klebsiella pneumoniae; Neoplasms; Neutropenia; Retrospective Studies | 2022 |
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.
Topics: Anti-Infective Agents; Carbapenems; Cohort Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Neutropenia; Piperacillin; Retrospective Studies; Tazobactam; Transplantation, Homologous | 2023 |
Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study.
Topics: Adult; Anti-Infective Agents; Bacteremia; Carbapenems; Humans; Neutropenia; Pseudomonas aeruginosa; Retrospective Studies; Sepsis | 2022 |
Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Neutropenia; Retrospective Studies; Shock, Septic | 2023 |
Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Gram-Negative Bacterial Infections; Humans; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Sepsis; Stenotrophomonas maltophilia | 2023 |
Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Female; Hematologic Neoplasms; Humans; Klebsiella Infections; Male; Neutropenia; Prevalence; Retrospective Studies; Shock, Septic | 2023 |
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors | 2023 |
Colonization by multidrug-resistant bacteria in hematological patients undergoing hematopoietic stem cell transplantation and clinical outcomes: A single-center retrospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Klebsiella pneumoniae; Neutropenia; Retrospective Studies; Sepsis | 2023 |
The efficacy of mesenchymal stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model.
Topics: Animals; Carbapenems; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Klebsiella pneumoniae; Mesenchymal Stem Cell Transplantation; Mice; Mice, Inbred BALB C; Neutropenia; Sepsis | 2020 |
Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Carbapenems; Controlled Before-After Studies; Female; Humans; Interrupted Time Series Analysis; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Practice Guidelines as Topic; Retrospective Studies; Stem Cell Transplantation; Vancomycin | 2020 |
The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Binding Sites, Antibody; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Immunoglobulin G; Klebsiella pneumoniae; Macrophages; Mice; Mice, Inbred C57BL; Neutropenia; Phagocytosis; Respiratory Tract Infections | 2020 |
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Neutropenia | 2017 |
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2017 |
Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Models, Animal; Drug Therapy, Combination; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Neutropenia; Treatment Outcome | 2013 |
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Time Factors | 2013 |
Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of bacteraemia isolates in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Young Adult | 2015 |
Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; New York City; Prevalence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2016 |
Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Fever; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Neutropenia; Pakistan; Vancomycin Resistance | 2008 |
Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppression Therapy; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Pneumonia, Bacterial; Rifampin; Treatment Outcome | 2009 |
Fulminant septicemia of Bacillus cereus resistant to carbapenem in a patient with biphenotypic acute leukemia.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacillus cereus; Bacteremia; beta-Lactam Resistance; Brain Stem; Carbapenems; Fever; Gram-Positive Bacterial Infections; Humans; Leukemia, Biphenotypic, Acute; Liver; Lung; Male; Microbial Sensitivity Tests; Neutropenia; Remission Induction | 2008 |
A patient with acute myeloid leukemia who developed fatal pneumonia caused by carbapenem-resistant Bacillus cereus.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bacillaceae Infections; Bacillus cereus; beta-Lactam Resistance; Carbapenems; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lung; Male; Middle Aged; Neutropenia; Pneumonia, Bacterial; Remission Induction; Tomography, X-Ray Computed | 2009 |
Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States.
Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Cancer Care Facilities; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Retrospective Studies; United States; Urine | 2011 |
Efficacy and safety of doripenem for sepsis with neutropenia in Japanese patients with hematologic diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Liver; Male; Middle Aged; Neutropenia; Prospective Studies; Sepsis | 2012 |
[beta-Lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Endocarditis, Bacterial; Humans; Molecular Structure; Monobactams; Neutropenia; Penicillins; Respiratory Tract Infections; Soft Tissue Infections; Staphylococcal Skin Infections; Urinary Tract Infections | 2003 |
[Clinical analysis of antibiotic treatment for febrile neutropenia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Anti-Bacterial Agents; Carbapenems; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multivariate Analysis; Neutropenia; Retrospective Studies | 2005 |
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
Topics: Adult; Aged; Bacteremia; Carbapenems; Case-Control Studies; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Neoplasms; Neutropenia; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Texas | 2007 |
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors | 2007 |
[Clinical evaluation of biapenem for febrile neutropenia in patients with hematological disorders].
Topics: Anemia, Aplastic; Carbapenems; Fever; Hematologic Diseases; Humans; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Myelodysplastic Syndromes; Neutropenia; Thienamycins; Treatment Outcome | 2007 |
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2008 |
Pharmacokinetics of meropenem in febrile neutropenic patients. Swedish study group.
Topics: Adult; Aged; Aged, 80 and over; Carbapenems; Drug Administration Schedule; Female; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins | 1997 |